Get the Stockscreener App
49.70
0.06%
0.03
After Hours:
49.67
-0.03
-0.06%
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Forecast
The State Street Spdr S P Pharmaceuticals Etf (XPH) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $45.05, representing a -9.35% decrease from the current price of $49.70. The highest analyst price target is $47.40, and the lowest is $42.70.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month XPH Price Target
Average 49.34
(-0.72% Downside)
Is State Street Spdr S P Pharmaceuticals Etf (XPH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.00 | Neutral |
| STOCH(9,6) | 80.77 | Sell |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | 0.5369 | Buy |
| ADX(14) | 18.31 | Neutral |
| William %R | -10.33 | Sell |
| CCI(14) | 103.86 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
49.00
Buy
|
49.06
Buy
|
| MA20 |
48.57
Buy
|
48.65
Buy
|
| MA50 |
47.77
Buy
|
47.51
Buy
|
| MA100 |
45.21
Buy
|
45.99
Buy
|
| MA200 |
43.68
Buy
|
44.73
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, XPH could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on XPH, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63 indicates that XPH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 80.77 indicates that XPH is oversold. This means that XPH price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that XPH is oversold. This suggests that XPH price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.31 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 103.86 indicates that XPH is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term XPH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about State Street Spdr S P Pharmaceuticals Etf financial reports and earnings history, State Street Spdr S P Pharmaceuticals Etf (XPH) stock could reach $39.99 by 2030, $41.61 by 2040 and $43.94 by 2050. See the projected annual prices until 2050 of the State Street Spdr S P Pharmaceuticals Etf stock below:
- State Street Spdr S P Pharmaceuticals Etf (XPH) is expected to reach an average price of $36.44 in 2035, with a high prediction of $36.84 and a low estimate of $34.00. This indicates an $-26.69% rise from the last recorded price of $49.70.
- State Street Spdr S P Pharmaceuticals Etf (XPH) stock is projected to chart a bullish course in 2040, with an average price target of $41.06, representing an $-17.39% surge from its current level. The forecast ranges from a conservative $39.69 to a sky-high $41.61.
- Our analysts predict State Street Spdr S P Pharmaceuticals Etf (XPH) to jump -20.85% by 2045, soaring from $38.02 to an average price of $39.34, potentially reaching $42.89. While $38.02 is the low estimate, the potential upside is significant.
- State Street Spdr S P Pharmaceuticals Etf (XPH) stock is expected to climb by 2050, reaching an average of $43.90, a $-11.67% jump from its current level. However, a wide range of estimates exists, with high and low targets of $43.94 and $40.29, respectively, highlighting the market's uncertainty.
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Year by Year Forecast
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2025
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) is expected to reach an average price of $38.87 in 2025, with a high prediction of $47.78 and a low estimate of $29.96. This indicates an -21.79% fall from the last recorded price of $49.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2025 | $43.77 | $42.70 | $47.40 | -11.93% |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2026
The predicted value for State Street Spdr S P Pharmaceuticals Etf (XPH) in 2026 is set at an average of $49.88. Estimates vary from a peak of $55.98 to a trough of $43.78, indicating an +0.36% surge from the present price of $49.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $48.13 | $43.78 | $48.83 | -3.16% |
| February, 2026 | $50.31 | $47.23 | $51.16 | +1.23% |
| March, 2026 | $53.34 | $49.10 | $54.26 | +7.33% |
| April, 2026 | $55.34 | $51.38 | $55.98 | +11.35% |
| May, 2026 | $53.15 | $49.06 | $55.18 | +6.94% |
| June, 2026 | $48.66 | $48.31 | $53.06 | -2.09% |
| July, 2026 | $49.02 | $47.04 | $50.15 | -1.37% |
| August, 2026 | $52.56 | $48.50 | $52.96 | +5.76% |
| September, 2026 | $51.70 | $50.59 | $53.04 | +4.03% |
| October, 2026 | $50.68 | $48.16 | $53.48 | +1.97% |
| November, 2026 | $48.15 | $47.56 | $50.25 | -3.12% |
| December, 2026 | $47.07 | $45.78 | $49.01 | -5.29% |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for State Street Spdr S P Pharmaceuticals Etf (XPH) is $44.93, with a high forecast of $52.25 and a low forecast of $37.60. This indicates an -9.60% decrease from the last price of $49.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $47.64 | $45.90 | $48.11 | -4.14% |
| February, 2027 | $47.79 | $46.77 | $52.25 | -3.84% |
| March, 2027 | $44.86 | $43.24 | $48.22 | -9.74% |
| April, 2027 | $43.80 | $43.02 | $46.71 | -11.87% |
| May, 2027 | $43.07 | $39.91 | $43.85 | -13.34% |
| June, 2027 | $43.08 | $40.44 | $44.96 | -13.32% |
| July, 2027 | $44.93 | $41.64 | $46.16 | -9.59% |
| August, 2027 | $41.79 | $41.75 | $46.27 | -15.91% |
| September, 2027 | $42.03 | $37.60 | $42.08 | -15.43% |
| October, 2027 | $38.87 | $37.84 | $42.62 | -21.79% |
| November, 2027 | $43.73 | $38.96 | $44.05 | -12.01% |
| December, 2027 | $44.00 | $41.71 | $44.50 | -11.47% |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2028
In 2028, State Street Spdr S P Pharmaceuticals Etf (XPH) is projected to reach an average price of $41.47, with a high projection of $44.34 and a low estimate of $38.60. This indicates an -16.56% fall from the last price of $49.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $41.39 | $40.79 | $44.34 | -16.72% |
| February, 2028 | $39.82 | $39.03 | $43.90 | -19.88% |
| March, 2028 | $41.98 | $38.88 | $42.36 | -15.53% |
| April, 2028 | $41.88 | $40.52 | $43.38 | -15.73% |
| May, 2028 | $40.39 | $39.84 | $43.30 | -18.73% |
| June, 2028 | $42.40 | $39.65 | $42.50 | -14.68% |
| July, 2028 | $42.42 | $42.21 | $43.97 | -14.64% |
| August, 2028 | $39.28 | $39.20 | $43.16 | -20.97% |
| September, 2028 | $41.31 | $39.05 | $41.31 | -16.88% |
| October, 2028 | $42.11 | $40.72 | $42.31 | -15.27% |
| November, 2028 | $40.10 | $38.60 | $42.20 | -19.31% |
| December, 2028 | $40.65 | $39.84 | $41.87 | -18.20% |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2029
The 2029 price forecast for State Street Spdr S P Pharmaceuticals Etf Stock (XPH) is $39.81 on average, with a high prediction of $45.28 and a low estimate of $34.33. This represents an -19.90% decrease from the previous price of $49.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $43.38 | $39.88 | $43.41 | -12.71% |
| February, 2029 | $42.92 | $42.10 | $43.68 | -13.64% |
| March, 2029 | $42.10 | $42.10 | $43.97 | -15.29% |
| April, 2029 | $37.46 | $36.94 | $42.08 | -24.62% |
| May, 2029 | $34.92 | $34.53 | $38.26 | -29.73% |
| June, 2029 | $37.27 | $34.33 | $37.27 | -25.00% |
| July, 2029 | $41.28 | $37.13 | $41.86 | -16.94% |
| August, 2029 | $41.66 | $40.59 | $42.78 | -16.17% |
| September, 2029 | $44.88 | $41.62 | $45.05 | -9.69% |
| October, 2029 | $42.20 | $41.61 | $45.28 | -15.08% |
| November, 2029 | $38.80 | $38.54 | $43.07 | -21.93% |
| December, 2029 | $39.99 | $38.55 | $40.67 | -19.54% |
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Price Forecast for 2030
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) is expected to reach an average price of $38.53 in 2030, with a high forecast of $47.44 and a low forecast of $29.62. This signifies an -22.47% decrease from the last price of $49.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $36.67 | $35.82 | $39.99 | -26.21% |
| February, 2030 | $37.88 | $36.57 | $39.87 | -23.78% |
| March, 2030 | $36.99 | $36.66 | $37.97 | -25.58% |
| April, 2030 | $34.70 | $34.03 | $37.47 | -30.18% |
| May, 2030 | $35.01 | $34.20 | $37.24 | -29.56% |
| June, 2030 | $37.21 | $33.69 | $37.32 | -25.13% |
| July, 2030 | $39.41 | $37.24 | $39.44 | -20.70% |
| August, 2030 | $44.66 | $39.47 | $44.74 | -10.14% |
| September, 2030 | $44.91 | $43.67 | $45.88 | -9.64% |
| October, 2030 | $45.92 | $44.37 | $47.44 | -7.61% |
| November, 2030 | $34.90 | $33.52 | $46.19 | -29.78% |
| December, 2030 | $33.89 | $29.62 | $35.85 | -31.81% |
0.47%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):